China still a good option
The ongoing rise of the Chinese middle class will drag up demand for New Zealand products there in the future.
China's infant formula market upheaval is creating short-term challenges for Southland milk processor Mataura Valley Milk (MVM).
Its third party customer base is dwindling as customers deal with inventory issues triggered by changing dynamics in China.
MVM is 75% owned by a2 Milk Company (a2), which is also facing declining volumes in infant formula sales in China.
At an a2 investor presentation last week, MVM chief executive Bernard May says the short-term outlook for Mataura is "more challenging than anticipated".
The drop in infant formula business means the factory will be producing more commodity products - whole milk and skim milk powders. This will adversely impact earnings, he says.
However, a2 plans to increase MVM utilisation over time. Next year it will start producing a2 instant WMP. The plant is expected to reach profitability within five years.
May says as a2 expands its product portfolio in the future, MVM will have a key role in the production process.
a2 is also looking at MVM making its infant formula brands alongside Synlait for both English and Chinese labels. A blending and canning facility is also being planned at Mataura.
a2 acquired the majority stake in MVM three months ago for $268 million from China Animal Husbandry Group (CAHG), which will retain a 25% interest.
May told investors that MVM is a world-class facility - one of the most technically advanced nutritional sites globally.
He says the purchase allows the company access to existing supply agreements with local farmers engaged to supply the highest quality milk and significantly transition to A1-protein free in three seasons.
It also provides a2 supplier and geographic diversification and complements existing supply from Synlait.
While the Chinese infant formula market remains the largest and most attractive in the world, volume growth is declining.
At last week’s investor presentation, a2 chief market strategist Eleanor Khor noted that with declining volumes, retail pricing is also now under pressure and making conditions even more challenging is the fact that consumers are no longer actively prioritising international brands: instead, they are looking for brands that resonate, and local competitors are more effectively connecting with consumers in their home market than multinational corporations.
“This is potentially unsurprising given the speed at which the consumer landscape is evolving. Generations are getting ‘shorter’ and the market is now made up of mostly post-‘90s mums with very different attitudes and behaviours,” says Khor.
The changing Chinese market has prompted a change in a2’s growth strategy.
Managing director David Bortolussi says the China infant milk formula market has experienced unprecedented change over the past 12 months, which has required them to adapt their growth strategy.
“We have reviewed our brand positioning to ensure continued distinctiveness and to capture the full potential of our China label and English label products in key channels.”
European milk processors are eyeing more cheese and milk powder exports into South America following a landmark trade agreement signed last month.
Two European dairy co-operatives are set to merge and create a €14 billion business.
DairyNZ's Kirsty Verhoek ‘walks the talk’, balancing her interests in animal welfare, agricultural science and innovative dairy farming.
"We at Ministry for Primary Industries (MPI) and you at Dairy News said over six months ago that the dairy industry would bounce back, and it has done so with interest.”
Wairarapa sheep and beef farmer Karen Williams is the new chief executive of Irrigation New Zealand.
Whole milk powder prices on Global Dairy Trade (GDT) remains above long run averages and a $10/kgMS milk price for the season remains on the card, says ASB senior economist Chris Tennent-Brown.
OPINION: The end-of-year booze-up at the posh Northern Club in Auckland must have been a beauty, as the legal 'elite'…
OPINION: It divides opinion, but the House has passed the first reading of the Gene Technology Bill.